Matthias Bodenstedt - 08 Oct 2025 Form 4 Insider Report for MoonLake Immunotherapeutics (MLTX)

Role: Chief Financial Officer
Signature: /s/ Matthias Bodenstedt
Issuer symbol: MLTX
Transactions as of: 08 Oct 2025
Net transactions value: +$98,808
Form type: 4
Filing time: 09 Oct 2025, 09:01:51 UTC
Previous filing: 03 Mar 2025
Next filing: 22 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Bodenstedt Matthias	Chief Financial Officer	C/O MOONLAKE IMMUNOTHERAPEUTICS, DORFSTRASSE 29, ZUG, SWITZERLAND	/s/ Matthias Bodenstedt	09 Oct 2025	0001920545

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MLTX	Class A ordinary shares, par value $0.0001 per share	Purchase	$98,808	+10,870	+1.8%	$9.09	627,536	08 Oct 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $9.085 to $9.091244. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.

Content

The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $9.085 to $9.091244. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.